BridgeMD
New treatment option for Acute Pancreatitis
Official title Preventing the Recurrence of Acute Pancreatitis by Alcohol and Smoking Cessation
ClinicalTrials.gov ID: NCT04647097
What this study is testing
- What it's testing
- Recurrence of acute pancreatitis (AP) is often facilitated by regular alcohol consumption and smoking. An applied lifestyle intervention focusing on the cessation of alcohol consumption and smoking might prevent the recurrence of AP.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patient hospitalized with alcohol-induced AP (defined by the revised Atlanta criteria 38)
- Every day smoker (defined as an adult patient who smoked at least 100 cigarettes in his or her lifetime, and now smokes on a daily basis; as per the...
- Aged 18-80 years
- Provided written informed consent
- Willing to participate in the intervention in every three months
You likely can't join if
- Possible etiologies for AP other than alcohol (eg. gallstone-related, hypertriglyceridemia above 11.5 mM 40-42, hypercalcemia, viral infection) if...
- Untreated, decompensated or severe mMajor psychiatric illnesses (e.g. schizophrenia, bipolar disorder, dementia)
- Currently taking part in a smoking cessation program
- Undergoing active or palliative treatment for malignancy
- Pregnancy, breastfeeding
- Life expectancy is less than two years
See the full eligibility criteria
- Patient hospitalized with alcohol-induced AP (defined by the revised Atlanta criteria 38)
- Every day smoker (defined as an adult patient who smoked at least 100 cigarettes in his or her lifetime, and now smokes on a daily basis; as per the CDC definition), with at least 1-year history of smoking
- Aged 18-80 years
- Provided written informed consent
- Willing to participate in the intervention in every three months
- Possible etiologies for AP other than alcohol (eg. gallstone-related, hypertriglyceridemia above 11.5 mM 40-42, hypercalcemia, viral infection) if the etiological cannot be terminated during the index admission (lack of...
- Untreated, decompensated or severe mMajor psychiatric illnesses (e.g. schizophrenia, bipolar disorder, dementia)
- Currently taking part in a smoking cessation program
- Undergoing active or palliative treatment for malignancy
- Pregnancy, breastfeeding
- Life expectancy is less than two years
- Didn't agreed to participate
- Other
The study team makes the final eligibility decision.
Where it's taking place
- Pécs, Hungary
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pécs, Hungary. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.